Similar Articles
Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
Ali Erhan Özdemirel, Serdar Can Güven, Zühre Sarı Sürmeli, Ayla Özyuvalı, Memet Kurt, Diana Rüstemova, Ayşe Peyman Yalçın Sayan, Hüseyin Tutkan, Şebnem Ataman
DOI: 10.46497/ArchRheumatol.2022.9819
Validity and reliability of the Turkish version of Psoriasis Epidemiology Screening Tool for the detection of psoriatic arthritis in patients with psoriasis
Serdar Kaymaz, Uğur Karasu, Nida Kaçar, Hakan Alkan
DOI: 10.46497/ArchRheumatol.2022.8221
The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients
Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed
DOI: 10.46497/ArchRheumatol.2022.9307
Insulin resistance and adverse lipid profile in untreated very early rheumatoid arthritis patients: A single-center, cross-sectional study in China
Lu Ye, Xin Zhang, Huaxiang Wu, Yahui Chen, Haibo Zhou, Qiaohong Wang, Weihong Xu
DOI: 10.46497/ArchRheumatol.2022.9117
Serum cystatin C and βeta-2 microglobulin as potential biomarkers in children with lupus nephritis
Eman Baraka, Nashwa Hashaad, Walid Abdelhalim, Gehan Elolemy
DOI: 10.46497/ArchRheumatol.2023.8520
Muscle architecture in patients with primary Sjögren syndrome
Duygu Tecer, Dilek Eker Büyüksireci, Zafer Günendi, Jale Meray, Feride Göğüs
DOI: 10.46497/ArchRheumatol.2023.9414
Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations
Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein
DOI: 10.46497/ArchRheumatol.2023.9638
Examining the functions of the vascular endothelial growth factor/hypoxia-inducible factor signaling pathway in psoriatic arthritis
Yavuz Kiliç, Derya Guzel Erdogan, Merve Baykul, Kemal Nas
DOI: 10.46497/ArchRheumatol.2023.9898
Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study
Tumay Ak, Leyla Mustafayeva, Ali Yagiz Ayla, Yeliz Celik, Gunay Can, Serdal Ugurlu
DOI: 10.46497/ArchRheumatol.2024.10050
Correlation between clinical disease activity and sacroiliac magnetic resonance imaging detection in axial spondyloarthropathy
Ozenc Inan, Ebru Aytekin, Yasemin Pekin Dogan, Ilhan Nahit Mutlu, Kübra Aydemir, Nuran Oz, Nil Sayiner Caglar
DOI: 10.46497/ArchRheumatol.2024.10401
The relationship between clinical parameters and ultrasonographic enthesitis assessment in patients with spondyloarthritis
Gunay Er, Deniz Palamar, Kenan Akgün, İbrahim Asoğlu, Hidayet Sarı
DOI: 10.46497/ArchRheumatol.2024.10224
Difficult-to-treat axial spondyloarthritis patients
Tahir Saygın Öğüt, Funda Erbasan, Mehmet Fatih Şahiner, Mine Nokay, Ayşe Yörük Öğüt, Melis Dilbil, Mustafa Ender Terzioğlu, Veli Yazısız
DOI: 10.46497/ArchRheumatol.2024.10567